Table 3 Univariate and multivariate analyses of overall survival in hepatocellular carcinoma patients of TCGA
From: Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma
Variables | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
Hazard ratio (95% CI) | P-value | Hazard ratio (95% CI) | P-value | |
Age | 1.007 (0.988–1.026) | 0.495 | 1.010 (0.990–1.030) | 0.322 |
Gender | 0.755 (0.461–1.237) | 0.264 | 1.168 (0.668–2.044) | 0.586 |
Histologic grade | 0.915 (0.660–1.269) | 0.596 | 0.888 (0.624–1.264) | 0.510 |
Pathologic stage | 1.782 (1.388–2.288) | 5.85E−06 | 0.893 (0.328–2.428) | 0.825 |
T classification | 1.725 (1.370–2.172) | 3.50E−06 | 1.784 (0.732–4.348) | 0.203 |
M classification | 3.141 (0.984–10.021) | 0.053 | 1.505 (0.387–5.852) | 0.555 |
N classification | 1.604 (0.391–6.576) | 0.512 | 2.267 (0.353–14.556) | 0.388 |
Prognostic model | 1. 126 (1.089–1.165) | 5.02E−12 | 1.120 (1.079–1.162) | 1.88E−09 |